Last reviewed · How we verify
trimetaphan
trimetaphan is a drug. It is currently in unknown development for Controlled Hypotension, Hypertensive Emergencies, Pulmonary edema.
At a glance
| Generic name | trimetaphan |
|---|---|
| Target | Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4 |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Approved indications
- Controlled Hypotension
- Hypertensive Emergencies
- Pulmonary edema
Common side effects
Key clinical trials
- Acute Sympathetic Blockade and Endogenous Glucose Production (Phase 1)
- The Autonomic Nervous System and the Metabolic Syndrome (NA)
- Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Aim 1 of Rare Diseases Clinical Research Network (RDCRN) Project 2 (Phase 1)
- Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension (Phase 1)
- Cardiovascular Regulation: Autonomic/Metabolic Mechanisms PO1 HL56693, Project 4: Cardiovascular Regulation: Autonomic/Metabolic Mechanisms (NA)
- Autonomic Nervous System and Chronic Fatigue Syndrome (Phase 1)
- The Autonomic Nervous System and Obesity (Phase 1)
- Obesity, Hypertension in African American Women, Neuro-metabolic Mechanism (Phase 1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- trimetaphan CI brief — competitive landscape report
- trimetaphan updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about trimetaphan
What is trimetaphan?
trimetaphan is a pharmaceutical drug, indicated for Controlled Hypotension, Hypertensive Emergencies, Pulmonary edema.
What is trimetaphan used for?
trimetaphan is indicated for Controlled Hypotension, Hypertensive Emergencies, Pulmonary edema.
What development phase is trimetaphan in?
trimetaphan is in unknown.
What does trimetaphan target?
trimetaphan targets Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4.
Related
- Target: All drugs targeting Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
- Indication: Drugs for Controlled Hypotension
- Indication: Drugs for Hypertensive Emergencies
- Indication: Drugs for Pulmonary edema
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing